0 +

Report Audiences

0 %

Brand Controls

0 x

Provenance Coverage

Smart Logic

White-Label Reports

We render each lab's pharmacogenomic reports under its own brand — in clinician-facing and patient-facing formats — with source-level provenance from CPIC, DPWG, FDA labeling, and PharmGKB attached to every recommendation a licensed clinician reviews and releases.

Year

2026

Industry

White-Label PGx Reporting

SERVICE USED

Evidence Interpretation, Report Automation

Challenge

Off-the-shelf report templates carried a vendor's brand, addressed clinicians and patients in one dense voice, and made the evidence behind each recommendation hard to trace.

(spx® — the problem)

PGx results were delivered as generic, vendor-branded documents that undercut the lab's own identity, forced clinicians and patients to read the same dense format, and separated each recommendation from the CPIC, DPWG, and FDA sources behind it — leaving reviewers to reconstruct provenance by hand before they could stand behind what they released.

Play

Operational Overview

1:42 min overview

(spx® — solution)

Designing systems that replace coordination with execution

Most labs can run the assay long before they can produce a report a prescriber will trust and a patient can actually read. Building report software — layout, guideline logic, versioning, PDF rendering, accessibility — is a product effort few labs are staffed to own. Meanwhile referrals stall because the deliverable looks generic or off-brand.

Ship premium, fully branded PGx reports under your own name — without building a single line of report software.

SignalPGx renders provider, patient, and living-passport formats from one interpreted result set, each styled with your logo, colors, and clinical voice. SignalAI drafts the phenotype-to-recommendation narrative from CPIC, FDA, DPWG, and DailyMed evidence, and your medical director reviews and signs off before anything releases. The clinician owns every clinical decision — the platform never diagnoses or auto-releases.

One interpretation, three purpose-built deliverables that carry your brand:

Provider-grade clinical summary reports
Plain-language patient reports
Living passport for lifelong reference
Full brand and template control

Every report is generated from the same governed evidence base and interpretation engine, so a CYP2D6 poor metabolizer reads identically across formats and over time. Templates are version-controlled, and each release carries the guideline versions and sign-off it was built on — no template drift, no silent content changes between batches.

Reports flow from the same result set your team already reviews, so nothing changes about how the lab confirms and releases. Delivery fits existing pathways — secure PDF, portal, or downstream systems — and the branded output slots into the referral experience prescribers and patients already expect from you.

As volume grows, you add report types and refresh branding from configuration rather than a development sprint. New guideline updates propagate to templates centrally, so quality and consistency hold at scale instead of eroding with each new panel or client.

The lab launches a premium, on-brand PGx report line in weeks instead of quarters, and clinicians get a deliverable they trust — reviewed, signed, and unmistakably yours.

(spx® — Technology Stacks)

LOINC

HGNC

RxNorm

FHIR

(spx® — from the team)

Every report ships under the lab's brand, every recommendation traceable to its source.

Melissa Thompson

Head of Lab Partnerships, SignalPGx

Previous case

EHR + CDS Integrations

0 +

Report Audiences

0 %

Brand Controls

0 x

Provenance Coverage

Smart Logic

White-Label Reports

We render each lab's pharmacogenomic reports under its own brand — in clinician-facing and patient-facing formats — with source-level provenance from CPIC, DPWG, FDA labeling, and PharmGKB attached to every recommendation a licensed clinician reviews and releases.

Year

2026

Industry

White-Label PGx Reporting

SERVICE USED

Evidence Interpretation, Report Automation

Challenge

Off-the-shelf report templates carried a vendor's brand, addressed clinicians and patients in one dense voice, and made the evidence behind each recommendation hard to trace.

(spx® — the problem)

PGx results were delivered as generic, vendor-branded documents that undercut the lab's own identity, forced clinicians and patients to read the same dense format, and separated each recommendation from the CPIC, DPWG, and FDA sources behind it — leaving reviewers to reconstruct provenance by hand before they could stand behind what they released.

Play

Operational Overview

1:42 min overview

(spx® — solution)

Designing systems that replace coordination with execution

Most labs can run the assay long before they can produce a report a prescriber will trust and a patient can actually read. Building report software — layout, guideline logic, versioning, PDF rendering, accessibility — is a product effort few labs are staffed to own. Meanwhile referrals stall because the deliverable looks generic or off-brand.

Ship premium, fully branded PGx reports under your own name — without building a single line of report software.

SignalPGx renders provider, patient, and living-passport formats from one interpreted result set, each styled with your logo, colors, and clinical voice. SignalAI drafts the phenotype-to-recommendation narrative from CPIC, FDA, DPWG, and DailyMed evidence, and your medical director reviews and signs off before anything releases. The clinician owns every clinical decision — the platform never diagnoses or auto-releases.

One interpretation, three purpose-built deliverables that carry your brand:

Provider-grade clinical summary reports
Plain-language patient reports
Living passport for lifelong reference
Full brand and template control

Every report is generated from the same governed evidence base and interpretation engine, so a CYP2D6 poor metabolizer reads identically across formats and over time. Templates are version-controlled, and each release carries the guideline versions and sign-off it was built on — no template drift, no silent content changes between batches.

Reports flow from the same result set your team already reviews, so nothing changes about how the lab confirms and releases. Delivery fits existing pathways — secure PDF, portal, or downstream systems — and the branded output slots into the referral experience prescribers and patients already expect from you.

As volume grows, you add report types and refresh branding from configuration rather than a development sprint. New guideline updates propagate to templates centrally, so quality and consistency hold at scale instead of eroding with each new panel or client.

The lab launches a premium, on-brand PGx report line in weeks instead of quarters, and clinicians get a deliverable they trust — reviewed, signed, and unmistakably yours.

(spx® — Technology Stacks)

LOINC

HGNC

RxNorm

FHIR

(spx® — from the team)

Every report ships under the lab's brand, every recommendation traceable to its source.

Melissa Thompson

Head of Lab Partnerships, SignalPGx

Previous case

EHR + CDS Integrations

0 +

Report Audiences

0 %

Brand Controls

Smart Logic

White-Label Reports

We render each lab's pharmacogenomic reports under its own brand — in clinician-facing and patient-facing formats — with source-level provenance from CPIC, DPWG, FDA labeling, and PharmGKB attached to every recommendation a licensed clinician reviews and releases.

Year

2026

Industry

White-Label PGx Reporting

SERVICE USED

Evidence Interpretation, Report Automation

Challenge

Off-the-shelf report templates carried a vendor's brand, addressed clinicians and patients in one dense voice, and made the evidence behind each recommendation hard to trace.

(spx® — the problem)

PGx results were delivered as generic, vendor-branded documents that undercut the lab's own identity, forced clinicians and patients to read the same dense format, and separated each recommendation from the CPIC, DPWG, and FDA sources behind it — leaving reviewers to reconstruct provenance by hand before they could stand behind what they released.

Play

Operational Overview

1:42 min overview

(spx® — solution)

Designing systems that replace coordination with execution

Most labs can run the assay long before they can produce a report a prescriber will trust and a patient can actually read. Building report software — layout, guideline logic, versioning, PDF rendering, accessibility — is a product effort few labs are staffed to own. Meanwhile referrals stall because the deliverable looks generic or off-brand.

Ship premium, fully branded PGx reports under your own name — without building a single line of report software.

SignalPGx renders provider, patient, and living-passport formats from one interpreted result set, each styled with your logo, colors, and clinical voice. SignalAI drafts the phenotype-to-recommendation narrative from CPIC, FDA, DPWG, and DailyMed evidence, and your medical director reviews and signs off before anything releases. The clinician owns every clinical decision — the platform never diagnoses or auto-releases.

One interpretation, three purpose-built deliverables that carry your brand:

Provider-grade clinical summary reports
Plain-language patient reports
Living passport for lifelong reference
Full brand and template control

Every report is generated from the same governed evidence base and interpretation engine, so a CYP2D6 poor metabolizer reads identically across formats and over time. Templates are version-controlled, and each release carries the guideline versions and sign-off it was built on — no template drift, no silent content changes between batches.

Reports flow from the same result set your team already reviews, so nothing changes about how the lab confirms and releases. Delivery fits existing pathways — secure PDF, portal, or downstream systems — and the branded output slots into the referral experience prescribers and patients already expect from you.

As volume grows, you add report types and refresh branding from configuration rather than a development sprint. New guideline updates propagate to templates centrally, so quality and consistency hold at scale instead of eroding with each new panel or client.

The lab launches a premium, on-brand PGx report line in weeks instead of quarters, and clinicians get a deliverable they trust — reviewed, signed, and unmistakably yours.

(spx® — Technology Stacks)

LOINC

HGNC

RxNorm

FHIR

(spx® — from the team)

Every report ships under the lab's brand, every recommendation traceable to its source.

Melissa Thompson

Head of Lab Partnerships, SignalPGx

Previous case

EHR + CDS Integrations

0 +

Report Audiences

0 %

Brand Controls

0 x

Provenance Coverage

Smart Logic

White-Label Reports

We render each lab's pharmacogenomic reports under its own brand — in clinician-facing and patient-facing formats — with source-level provenance from CPIC, DPWG, FDA labeling, and PharmGKB attached to every recommendation a licensed clinician reviews and releases.

Year

2026

Industry

White-Label PGx Reporting

SERVICE USED

Evidence Interpretation, Report Automation

Challenge

Off-the-shelf report templates carried a vendor's brand, addressed clinicians and patients in one dense voice, and made the evidence behind each recommendation hard to trace.

(spx® — the problem)

PGx results were delivered as generic, vendor-branded documents that undercut the lab's own identity, forced clinicians and patients to read the same dense format, and separated each recommendation from the CPIC, DPWG, and FDA sources behind it — leaving reviewers to reconstruct provenance by hand before they could stand behind what they released.

Play

Operational Overview

1:42 min overview

(spx® — solution)

Designing systems that replace coordination with execution

Most labs can run the assay long before they can produce a report a prescriber will trust and a patient can actually read. Building report software — layout, guideline logic, versioning, PDF rendering, accessibility — is a product effort few labs are staffed to own. Meanwhile referrals stall because the deliverable looks generic or off-brand.

Ship premium, fully branded PGx reports under your own name — without building a single line of report software.

SignalPGx renders provider, patient, and living-passport formats from one interpreted result set, each styled with your logo, colors, and clinical voice. SignalAI drafts the phenotype-to-recommendation narrative from CPIC, FDA, DPWG, and DailyMed evidence, and your medical director reviews and signs off before anything releases. The clinician owns every clinical decision — the platform never diagnoses or auto-releases.

One interpretation, three purpose-built deliverables that carry your brand:

Provider-grade clinical summary reports
Plain-language patient reports
Living passport for lifelong reference
Full brand and template control

Every report is generated from the same governed evidence base and interpretation engine, so a CYP2D6 poor metabolizer reads identically across formats and over time. Templates are version-controlled, and each release carries the guideline versions and sign-off it was built on — no template drift, no silent content changes between batches.

Reports flow from the same result set your team already reviews, so nothing changes about how the lab confirms and releases. Delivery fits existing pathways — secure PDF, portal, or downstream systems — and the branded output slots into the referral experience prescribers and patients already expect from you.

As volume grows, you add report types and refresh branding from configuration rather than a development sprint. New guideline updates propagate to templates centrally, so quality and consistency hold at scale instead of eroding with each new panel or client.

The lab launches a premium, on-brand PGx report line in weeks instead of quarters, and clinicians get a deliverable they trust — reviewed, signed, and unmistakably yours.